Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

Kenneth L. Rock(Dana-Farber Cancer Institute), Colette F. Gramm(Dana-Farber Cancer Institute), Lisa Rothstein(Dana-Farber Cancer Institute), Karen Clark(Dana-Farber Cancer Institute), Ross L. Stein(Harvard University), Lawrence R. Dick(Harvard University), Daniel Hwang, Alfred L. Goldberg(Harvard University)

Cell

September 1, 1994

10.1016/s0092-8674(94)90462-6

Cited by 2,526

Abstract

Related Papers

Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.

Keiko Ozato, David H. Sachs|The Journal of Immunology|1981|572

Ubiquitin‐conjugating enzymes UBC4 and UBC5 mediate selective degradation of short‐lived and abnormal proteins.

Wolfgang Seufert, Stefan Jentsch|The EMBO Journal|1990|520

Assembly of MHC class I molecules analyzed in vitro

Alain Townsend, Tim Elliott, Vincenzo Cerundolo et al.|Cell|1990|487

The multicatalytic and 26 S proteases.

Martin Rechsteiner, Laura Hoffman, Wolfgang Dubiel|Journal of Biological Chemistry|1993|473

MHC-linked LMP gene products specifically alter peptidase activities of the proteasome

James J. Driscoll, Michael G. Brown, Daniel Finley et al.|Nature|1993|449